| J3245 | Injection, tildrakizumab, 1 mg | 4,400 | $110 | $484K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 390 | $50 | $19.2K |
| 17000 | The provider destroys a premalignant lesion using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. This code reports the destruction of the first or only lesion. | 560 | $30 | $18.4K |
| 17004 | The provider destroys 15 or more premalignant lesions using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. | 130 | $100 | $12.3K |
| J7308 | Aminolevulinic acid HCl for topical administration, 20%, single unit dosage form (354 mg) | 30 | $310 | $10.1K |
| 99212 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,… | 290 | $30 | $9.6K |
| 17003 | In this add–on procedure, the provider destroys a premalignant lesion using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. This code is appropriate for the second through… | 2,170 | $1 | $8.7K |
| 11102 | The provider biopsies a single skin lesion using a tangential (side–ways) approach; he shaves off the lesion or scoops it out with a knife or curette. | 150 | $60 | $8.4K |
| 17110 | The provider destroys benign lesions using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. This code reports the destruction of one to 14 lesions other than skin tags or… | 100 | $70 | $6.2K |
| 96574 | This code is used to report removal of hyperkeratotic (hardened, dry, scaly) skin lesions that appear precancerous followed by photodynamic therapy that exposes a lesion treated with a… | 30 | $180 | $6K |